These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
476 related items for PubMed ID: 12749431
21. Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women. Murphy MG, Weiss S, McClung M, Schnitzer T, Cerchio K, Connor J, Krupa D, Gertz BJ, MK-677/Alendronate Study Group. J Clin Endocrinol Metab; 2001 Mar; 86(3):1116-25. PubMed ID: 11238495 [Abstract] [Full Text] [Related]
22. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women. Papakitsou EF, Margioris AN, Dretakis KE, Trovas G, Zoras U, Lyritis G, Dretakis EK, Stergiopoulos K. Maturitas; 2004 Mar 15; 47(3):185-93. PubMed ID: 15036488 [Abstract] [Full Text] [Related]
23. A detailed assessment of alterations in bone turnover, calcium homeostasis, and bone density in normal pregnancy. Black AJ, Topping J, Durham B, Farquharson RG, Fraser WD. J Bone Miner Res; 2000 Mar 15; 15(3):557-63. PubMed ID: 10750571 [Abstract] [Full Text] [Related]
24. Correlation between bone markers and bone mineral density in postmenopausal women with osteoporosis. Hari Kumar KV, Muthukrishnan J, Verma A, Modi KD. Endocr Pract; 2008 Dec 15; 14(9):1102-7. PubMed ID: 19158049 [Abstract] [Full Text] [Related]
25. Relationships between serum adiponectin, leptin concentrations and bone mineral density, and bone biochemical markers in Chinese women. Wu N, Wang QP, Li H, Wu XP, Sun ZQ, Luo XH. Clin Chim Acta; 2010 May 02; 411(9-10):771-5. PubMed ID: 20184866 [Abstract] [Full Text] [Related]
26. Effect of strontium ranelate on serum leptin and bone turnover markers in women with established postmenopausal osteoporosis. Bayhan I, Dogan NU, Ozaksit G, Uygur D, Ugurlu N, Ugur M. J Reprod Med; 2013 May 02; 58(7-8):319-23. PubMed ID: 23947082 [Abstract] [Full Text] [Related]
27. Comparison of the effect of alendronate on lumbar bone mineral density and bone turnover in men and postmenopausal women with osteoporosis. Iwamoto J, Takeda T, Sato Y, Uzawa M. Clin Rheumatol; 2007 Feb 02; 26(2):161-7. PubMed ID: 16565894 [Abstract] [Full Text] [Related]
28. Correlations between bone turnover markers, serum magnesium and bone mass density in postmenopausal osteoporosis. Mederle OA, Balas M, Ioanoviciu SD, Gurban CV, Tudor A, Borza C. Clin Interv Aging; 2018 Feb 02; 13():1383-1389. PubMed ID: 30122910 [Abstract] [Full Text] [Related]
29. Quantitative ultrasound of bone and markers of bone turnover in Cushing's syndrome. Cortet B, Cortet C, Blanckaert F, d'Herbomez M, Marchandise X, Wémeau J-L, Decoulx M, Dewailly D. Osteoporos Int; 2001 Feb 02; 12(2):117-23. PubMed ID: 11303711 [Abstract] [Full Text] [Related]
30. Thyrotropin versus thyroid hormone in regulating bone density and turnover in premenopausal women. Baqi L, Payer J, Killinger Z, Hruzikova P, Cierny D, Susienkova K, Langer P. Endocr Regul; 2010 Apr 02; 44(2):57-63. PubMed ID: 20429634 [Abstract] [Full Text] [Related]
31. Relationship between bone turnover biomarkers, mandibular bone mineral density, and systemic skeletal bone mineral density in premenopausal and postmenopausal Indian women. Makker A, Singh MM, Mishra G, Singh BP, Jain GK, Jadhav S. Menopause; 2012 Jun 02; 19(6):642-9. PubMed ID: 22240638 [Abstract] [Full Text] [Related]
32. Determinants of one-year response of lumbar bone mineral density to alendronate treatment in elderly Japanese women with osteoporosis. Iwamoto J, Takeda T, Sato Y, Uzawa M. Yonsei Med J; 2004 Aug 31; 45(4):676-82. PubMed ID: 15344210 [Abstract] [Full Text] [Related]
33. The value of osteopontin in the assessment of bone mineral density status in postmenopausal women. Fodor D, Bondor C, Albu A, Simon SP, Craciun A, Muntean L. J Investig Med; 2013 Jan 31; 61(1):15-21. PubMed ID: 23117696 [Abstract] [Full Text] [Related]
34. Bone Turnover Markers for Osteoporosis Status Assessment at Baseline in Postmenopausal Pakistani Females. Naeem ST, Hussain R, Raheem A, Siddiqui I, Ghani F, Khan AH. J Coll Physicians Surg Pak; 2016 May 31; 26(5):408-12. PubMed ID: 27225148 [Abstract] [Full Text] [Related]
35. Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine. Guo CY, Weetman AP, Eastell R. Clin Endocrinol (Oxf); 1997 Mar 31; 46(3):301-7. PubMed ID: 9156039 [Abstract] [Full Text] [Related]
36. Bone mineral density: serum markers of bone turnover and their relationships in peritoneal dialysis. Negri AL, Barone R, Quiroga MA, Bravo M, Marino A, Fradinger E, Bogado CE, Zanchetta JR. Perit Dial Int; 2004 Mar 31; 24(2):163-8. PubMed ID: 15119637 [Abstract] [Full Text] [Related]
37. Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism. Guo CY, Thomas WE, al-Dehaimi AW, Assiri AM, Eastell R. J Clin Endocrinol Metab; 1996 Oct 31; 81(10):3487-91. PubMed ID: 8855790 [Abstract] [Full Text] [Related]
38. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD. J Bone Miner Res; 2000 Aug 31; 15(8):1526-36. PubMed ID: 10934651 [Abstract] [Full Text] [Related]
39. [Relationships between circulating matrix metalloproteinase-1, -2 and metalloproteinase-1 levels and bone biochemical markers and bone mineral density in Chinese postmenopausal women]. Guo LJ, Luo XH, Wu XP, Xie H, Zhou HD, Zhang H, Cao XZ, Liao EY. Zhonghua Yi Xue Za Zhi; 2005 Mar 23; 85(11):734-7. PubMed ID: 15949377 [Abstract] [Full Text] [Related]
40. Bone mineral density and bone turnover in relation to serum leptin, alpha-ketoglutarate and sex steroids in overweight and obese postmenopausal women. Filip R, Raszewski G. Clin Endocrinol (Oxf); 2009 Feb 23; 70(2):214-20. PubMed ID: 18547340 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]